Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -5.84%2.6B | 2.49%2.84B | 8.59%3.97B | -4.22%12.45B | -0.88%3.26B | -8.94%2.76B | 5.47%2.78B | -9.71%3.66B | -7.74%13B | -15.63%3.29B |
| Operating revenue | -8.46%2.54B | -6.31%2.54B | 13.78%3.91B | -1.89%12.16B | 1.99%3.24B | -7.37%2.78B | 11.33%2.71B | -9.29%3.44B | -8.84%12.4B | -13.50%3.17B |
| Cost of revenue | -9.56%1.98B | -9.62%1.98B | 11.59%2.76B | -9.01%9.2B | -6.76%2.35B | -14.04%2.19B | 16.09%2.19B | -21.71%2.48B | -9.21%10.11B | -21.46%2.52B |
| Gross profit | 8.38%621M | 48.11%862M | 2.29%1.21B | 12.55%3.25B | 18.24%914M | 17.66%573M | -21.56%582M | 33.26%1.18B | -2.17%2.89B | 11.22%773M |
| Operating expense | 1.26%561M | 2.39%557M | 4.79%612M | 9.17%2.16B | -2.07%473M | 12.83%554M | 8.15%544M | 17.03%584M | 1.44%1.97B | 3.21%483M |
| Selling and administrative expenses | ---- | ---- | ---- | -147.37%-141M | ---- | ---- | ---- | ---- | 22.97%-57M | ---- |
| -General and administrative expense | ---- | ---- | ---- | -147.37%-141M | ---- | ---- | ---- | ---- | 22.97%-57M | ---- |
| Depreciation amortization depletion | 5.04%125M | 7.69%126M | 10.34%128M | 7.71%475M | 11.82%123M | 9.17%119M | 4.46%117M | 4.50%116M | 0.46%441M | -1.79%110M |
| -Depreciation and amortization | 5.04%125M | 7.69%126M | 10.34%128M | 7.71%475M | 11.82%123M | 9.17%119M | 4.46%117M | 4.50%116M | 0.46%441M | -1.79%110M |
| Other operating expenses | 0.23%436M | 0.94%431M | 3.42%484M | 14.53%1.82B | 14.19%491M | 13.87%435M | 9.21%427M | 20.62%468M | 0.57%1.59B | 0.00%430M |
| Operating profit | 215.79%60M | 702.63%305M | -0.17%593M | 19.87%1.09B | 52.07%441M | 575.00%19M | -84.10%38M | 54.29%594M | -9.17%911M | 27.75%290M |
| Net non-operating interest income (expenses) | -5.45%-116M | -2.70%-114M | -7.48%-115M | -15.10%-442M | -26.37%-115M | -15.79%-110M | -19.35%-111M | -1.90%-107M | -22.68%-384M | -10.98%-91M |
| Non-operating interest income | ---- | ---- | ---- | 30.00%13M | ---- | ---- | ---- | ---- | -41.18%10M | ---- |
| Non-operating interest expense | 5.45%116M | 2.70%114M | 7.48%115M | 15.48%455M | 26.73%128M | 15.79%110M | 19.35%111M | 1.90%107M | 19.39%394M | 2.02%101M |
| Other net income (expenses) | -67.57%36M | 29.63%35M | -35.19%35M | -75.06%96M | -150.00%-95M | 131.25%111M | -25.00%27M | -84.07%54M | 1,380.77%385M | 43.28%-38M |
| Gain on sale of security | ---- | -200.00%-1M | -140.00%-2M | 316.67%13M | 166.67%8M | -116.67%-1M | --1M | --5M | -160.00%-6M | -1,300.00%-12M |
| Special income (charges) | ---- | ---- | ---- | -95.20%16M | ---- | ---- | ---- | ---- | 11,000.00%333M | ---- |
| -Less:Other special charges | ---- | ---- | ---- | 71.43%-4M | ---- | ---- | ---- | ---- | ---14M | ---- |
| -Gain on sale of property,plant,equipment | ---- | ---- | ---- | -96.24%12M | ---- | ---- | ---- | ---- | 10,533.33%319M | ---- |
| Other non-operating income (expenses) | -77.08%22M | 10.53%21M | -25.00%21M | 133.33%7M | 64.92%-134M | 357.14%96M | -29.63%19M | -91.69%28M | --3M | ---382M |
| Income before tax | -200.00%-20M | 591.30%226M | -5.18%513M | -18.20%746M | 43.48%231M | 139.22%20M | -125.27%-46M | -12.60%541M | 27.37%912M | 106.41%161M |
| Income tax | -300.00%-6M | 466.67%44M | -9.60%113M | -38.12%138M | -33.33%22M | 125.00%3M | -131.58%-12M | -23.31%125M | 55.94%223M | 175.00%33M |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -182.35%-14M | 635.29%182M | -3.85%400M | -11.76%608M | 63.28%209M | 143.59%17M | -123.61%-34M | -8.77%416M | 20.24%689M | 93.94%128M |
| Net income continuous operations | -182.35%-14M | 635.29%182M | -3.85%400M | -11.76%608M | 63.28%209M | 143.59%17M | -123.61%-34M | -8.77%416M | 20.24%689M | 93.94%128M |
| Noncontrolling interests | 0.00%3M | -50.00%2M | -25.00%3M | -25.00%12M | -66.67%1M | -25.00%3M | 0.00%4M | -20.00%4M | -68.00%16M | -40.00%3M |
| Net income attributable to the company | -221.43%-17M | 573.68%180M | -3.64%397M | -11.44%596M | 66.40%208M | 132.56%14M | -127.14%-38M | -8.65%412M | 28.68%673M | 104.92%125M |
| Preferred stock dividends | -20.00%4M | 25.00%5M | 25.00%5M | -33.33%18M | -28.57%5M | -28.57%5M | -42.86%4M | -33.33%4M | -32.50%27M | 0.00%7M |
| Other under preferred stock dividend | 4M | 0 | 0 | 0 | -94.05%5M | |||||
| Net income attributable to common stockholders | -377.78%-25M | 516.67%175M | -3.92%392M | -9.83%578M | 79.65%203M | 118.00%9M | -131.58%-42M | -8.31%408M | 60.65%641M | 109.26%113M |
| Diluted earnings per share | -366.67%-0.08 | 521.43%0.59 | -5.07%1.31 | -14.10%1.95 | 72.50%0.69 | 116.67%0.03 | -129.79%-0.14 | -12.66%1.38 | 59.86%2.27 | 110.53%0.4 |
| Basic earnings per share | -366.67%-0.08 | 514.29%0.58 | -4.38%1.31 | -14.16%1.94 | 70.00%0.68 | 116.67%0.03 | -129.79%-0.14 | -12.74%1.37 | 60.28%2.26 | 110.53%0.4 |
| Dividend per share | 5.88%0.315 | 5.88%0.315 | 5.88%0.315 | 6.25%1.19 | 6.25%0.2975 | 6.25%0.2975 | 6.25%0.2975 | 6.25%0.2975 | 5.66%1.12 | 5.66%0.28 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.